To evaluate the presented influences of resveratrol on malignant plasticity in CRC cells via p53 pathway, the controversy existing in the literature about resveratrol’s Sirt-1/p53 modulation needs to be discussed. Here, SIRT1 is linked to colorectal carcinoma.